Healthcare

FDA accepts supplemental Biologics License Application for Roche’s Lunsumio and Polivy combination for people with relapsed or refractory large B-cell lymphoma

Filing acceptance based on data from the phase III SUNMO study where subcutaneous Lunsumio VELO plus Polivy demonstrated a 59%...

F2G and Shionogi Announce Positive Topline Results From Global Phase 3 OASIS Study Evaluating Oral Olorofim Versus AmBisome® Followed by Standard of Care in Patients With Invasive Aspergillosis

Altus Copper Applies for Partial Revocation of Failure-to-File Cease Trade Order, Announces Proposed Financing and Provides Further Corporate Update

Vancouver, British Columbia--(Newsfile Corp. - June 17, 2026) - Altus Copper Corp. (the "Company") announces that it has applied to...

Omega Healthcare Named a Leader and the Only Star Performer in the Everest Group Revenue Cycle Management (RCM) Intelligent Operations PEAK Matrix® Assessment

Recognition highlights Omega Healthcare's legacy of leadership and commitment to empowering healthcare providers with outcomes-focused, AI-powered revenue cycle solutions BOCA...

Omega Healthcare Named a Leader and the Only Star Performer in the Everest Group Revenue Cycle Management (RCM) Intelligent Operations PEAK Matrix® Assessment

Recognition highlights Omega Healthcare's legacy of leadership and commitment to empowering healthcare providers with outcomes-focused, AI-powered revenue cycle solutions BOCA...

Omega Healthcare Named a Leader and the Only Star Performer in the Everest Group Revenue Cycle Management (RCM) Intelligent Operations PEAK Matrix® Assessment

Recognition highlights Omega Healthcare's legacy of leadership and commitment to empowering healthcare providers with outcomes-focused, AI-powered revenue cycle solutions BOCA...

error: Content is protected !!